BRCA1 and breast cancer: Robson ME et al. [40] performed a combined analysis of two retrospective cohorts of Ashkenazi Jewish women, showing that BC-specific survival was worse in women with BRCA1 mutations than in those without (the OS rate at 10 years was 62% versus 85%, p < 0.001, respectively).